MiR-206 promotes extracellular matrix accumulation and relieves infantile hemangioma through targeted inhibition of DNMT3A

References

• Castrén E, Salminen P, Vikkula M, et al. Inheritance patterns of infantile hemangioma. Pediatrics. 2016 Nov;138(5):e20161623. PubMed PMID: 27940781; eng.
   PubMed Web of Science ®Google Scholar
• Ng M, Knuth C, Weisbrod C, et al. Propranolol therapy for problematic infantile hemangioma. Ann Plast Surg. 2016 Mar;76(3):306–310. PubMed PMID: 26010350; eng.
   PubMed Web of Science ®Google Scholar
• Escarcega González CE, González Hernández A, Villalón CM, et al. β-Adrenoceptor blockade for infantile hemangioma therapy: do β3-Adrenoceptors play a role? J Vasc Res. 2018;55(3):159–168. PubMed PMID: 29936502; eng.
   PubMed Web of Science ®Google Scholar
• Goss JA, Konczyk DJ, Alomari MH, et al. Propranolol Treatment of Vascular Anomalies Other Than Infantile Hemangioma. J Craniofac Surg. 2017 Nov;28(8):2001–2003. PubMed PMID: 28968329; eng.
   PubMed Web of Science ®Google Scholar
• Janmohamed SR, Van Oosterhout M, De Laat PC, et al. Scoring the therapeutic effects of oral propranolol for infantile hemangioma: a prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS). J Am Acad Dermatol. 2015 Aug;73(2):258–263. PubMed PMID: 26183969; eng.
   PubMed Web of Science ®Google Scholar
• Byun JW, An HY, Yeom SD, et al. NDRG1 and FOXO1 regulate endothelial cell proliferation in infantile haemangioma. Exp Dermatol. 2018 Jun;27(6):690–693. PubMed PMID: 29569762; eng.
   PubMed Web of Science ®Google Scholar
• Soliman YS, Khachemoune A. Infantile hemangiomas: our current understanding and treatment options. Dermatol Online J. 2018 Sep 15;24(9):13030. PubMed PMID: 30677824; eng.
   PubMedGoogle Scholar
• Park H, Park H, Chung HY, et al. Comparative analysis of the extracellular matrix composition in proliferating and involuted infantile hemangiomas. Arch Plast Surg. 2015 Sep;42(5):544–551. PubMed PMID: 26430624; PubMed Central PMCID: PMCPMC4579164. eng.
   PubMedGoogle Scholar
• Whelan MC, Senger DR. Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A. J Biol Chem. 2003 Jan 3;278(1):327–334. PubMed PMID: 12399469; eng.
   PubMed Web of Science ®Google Scholar
• Liu Y, Senger DR. Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells. Faseb J. 2004 Mar;18(3):457–468. . PubMed PMID: 15003991; eng
   PubMed Web of Science ®Google Scholar
• Davis GE, Bayless KJ. An integrin and Rho GTPase-dependent pinocytic vacuole mechanism controls capillary lumen formation in collagen and fibrin matrices. Microcirculation. 2003 Jan;10(1):27–44; (New York, NY: 1994). PubMed PMID: 12610662; eng. .
   PubMed Web of Science ®Google Scholar
• Senger DR. Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am J Pathol. 1996 Jul;149(1):1–7. PubMed PMID: 8686733; PubMed Central PMCID: PMCPMC1865245. eng
   PubMed Web of Science ®Google Scholar
• Senger DR, Perruzzi CA, Streit M, et al. The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol. 2002 Jan;160(1):195–204. PubMed PMID: 11786413; PubMed Central PMCID: PMCPMC1867136. eng.
   PubMed Web of Science ®Google Scholar
• Senger DR, Claffey KP, Benes JE, et al. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13612–13617. PubMed PMID: 9391074; PubMed Central PMCID: PMCPMC28354. eng.
   PubMed Web of Science ®Google Scholar
• Komiya E, Sato H, Watanabe N, et al. Angiomodulin, a marker of cancer vasculature, is upregulated by vascular endothelial growth factor and increases vascular permeability as a ligand of integrin αvβ3. Cancer Med. 2014 Jun;3(3):537–549. PubMed PMID: 24737780; PubMed Central PMCID: PMCPMC4101744. eng.
   PubMed Web of Science ®Google Scholar
• Bayless KJ, Salazar R, Davis GE. RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins. Am J Pathol. 2000 May;156(5):1673–1683. . PubMed PMID: 10793078; PubMed Central PMCID: PMCPMC1876924. eng
   PubMed Web of Science ®Google Scholar
• Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014 Dec;15(12):786–801. . PubMed PMID: 25415508; PubMed Central PMCID: PMCPMC4316204. eng
   PubMed Web of Science ®Google Scholar
• Zhu L, Xie J, Liu Z, et al. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol. Cancer Sci. 2018 Jun;109(6):1981–1994. PubMed PMID: 29664206; PubMed Central PMCID: PMCPMC5989849. eng.
   PubMed Web of Science ®Google Scholar
• Khan ZA, Boscolo E, Picard A, et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest. 2008 Jul;118(7):2592–2599. PubMed PMID: 18535669; PubMed Central PMCID: PMCPMC2413184. eng.
   PubMed Web of Science ®Google Scholar
• Tan ST, Velickovic M, Ruger BM, et al. Cellular and extracellular markers of hemangioma. Plast Reconstr Surg. 2000 Sep;106(3):529–538. PubMed PMID: 10987458; eng.
   PubMed Web of Science ®Google Scholar
• Primo L, Seano G, Roca C, et al. Increased expression of alpha6 integrin in endothelial cells unveils a proangiogenic role for basement membrane. Cancer Res. 2010 Jul 15;70(14):5759–5769. PubMed PMID: 20570893; eng.
   PubMed Web of Science ®Google Scholar
• Bertoni N, Pereira LM, Severino FE, et al. Integrative meta-analysis identifies microRNA-regulated networks in infantile hemangioma. BMC Med Genet. 2016 Jan;15(17):4. PubMed PMID: 26772808; PubMed Central PMCID: PMCPMC4715339. eng.
   PubMed Web of Science ®Google Scholar
• Mishra S, Yadav T, Rani V. Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol. 2016 Feb;98:12–23. PubMed PMID: 26481951; eng.
   PubMed Web of Science ®Google Scholar
• Sandiford OA, Moore CA, Du J, et al. Human aging and cancer: role of miRNA in tumor microenvironment. Adv Exp Med Biol. 2018;1056:137–152. PubMed PMID: 29754179; eng.
   PubMed Web of Science ®Google Scholar
• Huang J, Jiang D, Zhao S, et al. Propranolol suppresses infantile hemangioma cell proliferation and promotes apoptosis by upregulating miR-125b expression. Anticancer Drugs. 2019 Jun;30(5):501–507. PubMed PMID: 30986805; eng.
   PubMed Web of Science ®Google Scholar
• Liu Z, Kang Z, Dai Y, et al. Long noncoding RNA LINC00342 promotes growth of infantile hemangioma by sponging miR-3619-5p from HDGF. Am J Physiol Heart Circ Physiol. 2019 Oct 1;317(4):H830–h839. PubMed PMID: 31469292; eng.
   PubMed Web of Science ®Google Scholar
• Yang L, Dai J, Li F, et al. The expression and function of miR-424 in infantile skin hemangioma and its mechanism. Sci Rep. 2017 Sep 19;7(1):11846. PubMed PMID: 28928430; PubMed Central PMCID: PMCPMC5605629. eng.
   PubMedGoogle Scholar
• Liu C, Zhao Z, Ji Z, et al. MiR-187-3p Enhances Propranolol Sensitivity of Hemangioma Stem Cells. Cell Struct Funct. 2019 Mar 20;44(1):41–50. PubMed PMID: 30713220; eng.
   PubMed Web of Science ®Google Scholar
• Li D, Li P, Guo Z, et al. Downregulation of miR-382 by propranolol inhibits the progression of infantile hemangioma via the PTEN-mediated AKT/mTOR pathway. Int J Mol Med. 2017 Mar;39(3):757–763. PubMed PMID: 28112362; eng.
   PubMed Web of Science ®Google Scholar
• Lacoste B, Raymond VA, Cassim S, et al. Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties. PloS One. 2017;12(2):e0171215. PubMed PMID: 28152020; PubMed Central PMCID: PMCPMC5289561 Chair at the Université de Montréal is a philanthropic chair administered by Université de Montréal that was initially founded through a joint initiative of the Canadian Liver Foundation and Novartis to help promote research in the field of liver disease. There are no patents, products in development or marketed products to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials. eng.
   PubMed Web of Science ®Google Scholar
• Cassim S, Raymond VA, Dehbidi-Assadzadeh L, et al. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment. Cell Cycle (Georgetown, Tex). 2018;17(7):903–916. PubMed PMID: 29633904; PubMed Central PMCID: PMCPMC6056217. eng.
   PubMed Web of Science ®Google Scholar
• Cassim S, Raymond VA, Lacoste B, et al. Metabolite profiling identifies a signature of tumorigenicity in hepatocellular carcinoma. Oncotarget. 2018 Jun 1;9(42):26868–26883. PubMed PMID: 29928490; PubMed Central PMCID: PMCPMC6003570. eng.
   PubMedGoogle Scholar
• Cassim S, Vučetić M, Ždralević M, et al. Warburg and beyond: the power of mitochondrial metabolism to collaborate or replace fermentative glycolysis in cancer. Cancers (Basel). 2020 Apr 30;12(5). DOI:10.3390/cancers12051119. PubMed PMID: 32365833; PubMed Central PMCID: PMCPMC7281550. eng.
   PubMed Web of Science ®Google Scholar
• Wu H, Tao J, Li X, et al. MicroRNA-206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto-oncogene and cyclin-dependent kinase 6 in mice. Hepatology. 2017 Dec;666:1952–1967. (Baltimore, Md). . PubMed PMID: 28714063; PubMed Central PMCID: PMCPMC5696004. eng.
   PubMed Web of Science ®Google Scholar
• Cai Y, Li H, Zhang Y. Downregulation of microRNA-206 suppresses clear cell renal carcinoma proliferation and invasion by targeting vascular endothelial growth factor A. Oncol Rep. 2016 Mar;35(3):1778–1786. . PubMed PMID: 26718123; eng
   PubMed Web of Science ®Google Scholar
• Sun Y, An N, Li J, et al. miRNA-206 regulates human pulmonary microvascular endothelial cell apoptosis via targeting in chronic obstructive pulmonary disease. J Cell Biochem. 2019 Apr;120(4):6223–6236. PubMed PMID: 30335896; eng.
   PubMed Web of Science ®Google Scholar
• Wang S, Ren L, Shen G, et al. The knockdown of MALAT1 inhibits the proliferation, invasion and migration of hemangioma endothelial cells by regulating MiR-206/VEGFA axis. Mol Cell Probes. 2020 Jun;51:101540. PubMed PMID: 32084582; eng.
   PubMed Web of Science ®Google Scholar
• Poojari S, Alabi OJ, Okubara PA, et al. SYBR(®) Green-based real-time quantitative reverse-transcription PCR for detection and discrimination of grapevine viruses. J Virol Methods. 2016 Sep;235:112–118. PubMed PMID: 27246908; eng.
   PubMed Web of Science ®Google Scholar
• Wessman LL, Andersen LK, Davis MDP. Incidence of diseases primarily affecting the skin by age group: population-based epidemiologic study in Olmsted County, Minnesota, and comparison with age-specific incidence rates worldwide. Int J Dermatol. 2018 Sep;57(9):1021–1034. . PubMed PMID: 29377079; PubMed Central PMCID: PMCPMC6064677. eng
   PubMed Web of Science ®Google Scholar
• Goss JA, Greene AK. Congenital Vascular Tumors. Otolaryngol Clin North Am. 2018 Feb;51(1):89–97. . PubMed PMID: 29217070; eng
   PubMed Web of Science ®Google Scholar
• North PE. Pediatric vascular tumors and malformations. Surg Pathol Clin. 2010 Sep 3;3:455–494. PubMed PMID: 26839221; eng.
   PubMedGoogle Scholar
• Peng SH, Yang KY, Chen SY, et al. [Research progresses in the pathogenesis, diagnosis and treatment of infantile hemangioma with PHACE syndrome]. Zhongguo Dang Dai Er Ke Za Zhi. 2017 Dec;19(12):1291–1296. PubMed PMID: 29237532; PubMed Central PMCID: PMCPMC7389804. chi.
   PubMedGoogle Scholar
• Korompelis P, Piperi C, Adamopoulos C, et al. Expression of vascular endothelial factor-A, gelatinases (MMP-2, MMP-9) and TIMP-1 in uterine leiomyomas. Clin Chem Lab Med. 2015 Aug;53(9):1415–1424. PubMed PMID: 25470608; eng.
   PubMed Web of Science ®Google Scholar
• Luo Y, Sinkeviciute D, He Y, et al. The minor collagens in articular cartilage. Protein Cell. 2017 Aug;8(8):560–572. PubMed PMID: 28213717; PubMed Central PMCID: PMCPMC5546929. eng.
   PubMed Web of Science ®Google Scholar
• Rotter A, De Oliveira ZNP. Infantile hemangioma: pathogenesis and mechanisms of action of propranolol. JDDG. 2017 Dec;15(12):1185–1190. . PubMed PMID: 29193649; eng
   Google Scholar
• Taran K, Wnęk A, Kobos J, et al. Tissue and serum mRNA profile of MMPs-2/9 as a potential novel biomarker for the most individual approach in infantile hemangiomas and cancer disease. Immunobiology. 2017 Nov;222(11):1035–1042. PubMed PMID: 28601470; eng.
   PubMed Web of Science ®Google Scholar
• PubMed PMID: 29542173; eng, Wang Y, Xu H, Si L, et al. MiR-206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11. Prostate. 2018 May;78(7):479–490. .
   PubMed Web of Science ®Google Scholar
• Meng X, Fu R. miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells. Onco Targets Ther. 2018;11:1757–1765. PubMed PMID: 29636622; PubMed Central PMCID: PMCPMC5881530. eng.
   PubMed Web of Science ®Google Scholar
• Jiao D, Chen J, Li Y, et al. miR-1-3p and miR-206 sensitizes HGF-induced gefitinib-resistant human lung cancer cells through inhibition of c-Met signalling and EMT. J Cell Mol Med. 2018 Jul;22(7):3526–3536. PubMed PMID: 29664235; PubMed Central PMCID: PMCPMC6010770. eng.
   PubMed Web of Science ®Google Scholar
• Correia De Sousa M, Gjorgjieva M, Dolicka D, et al. Deciphering miRNAs’ Action through miRNA Editing. Int J Mol Sci. 2019 Dec 11;20(24). DOI:10.3390/ijms20246249. PubMed PMID: 31835747; PubMed Central PMCID: PMCPMC6941098. eng.
   PubMed Web of Science ®Google Scholar
• Chen L, Heikkinen L, Wang C, et al. Trends in the development of miRNA bioinformatics tools. Brief Bioinform. 2019 Sep 27;20(5):1836–1852. PubMed PMID: 29982332; PubMed Central PMCID: PMCPMC7414524. eng.
   PubMed Web of Science ®Google Scholar
• Wang X, Yu B, Jin Q, et al. Regulation of laryngeal squamous cell cancer progression by the lncRNA RP11-159K7.2/miR-206/DNMT3A axis. J Cell Mol Med. 2020 Jun;24(12):6781–6795. PubMed PMID: 32363688; PubMed Central PMCID: PMCPMC7299727. eng.
   PubMed Web of Science ®Google Scholar
• Ferrari L, Carugno M, Bollati V. Particulate matter exposure shapes DNA methylation through the lifespan. Clin Epigenetics. 2019 Aug 30;11(1):129. PubMed PMID: 31470889; PubMed Central PMCID: PMCPMC6717322. eng.
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007 Feb 23;128(4):683–692. PubMed PMID: 17320506; PubMed Central PMCID: PMCPMC3894624. eng.
   PubMed Web of Science ®Google Scholar
• Shi W, Tang T, Li X, et al. Methylation-mediated silencing of miR-133a-3p promotes breast cancer cell migration and stemness via miR-133a-3p/MAML1/DNMT3A positive feedback loop. J Exp Clin Cancer Res. 2019 Oct 28;38(1):429. PubMed PMID: 31660998; PubMed Central PMCID: PMCPMC6819615. eng.
   PubMed Web of Science ®Google Scholar
• Liu T, Wu X, Chen T, et al. Downregulation of DNMT3A by miR-708-5p inhibits lung cancer stem cell-like phenotypes through repressing Wnt/β-catenin signaling. Clin Cancer Res off J Am Assoc Cancer Res. 2018 Apr 1;24(7):1748–1760. PubMed PMID: 28972040; eng.
   PubMed Web of Science ®Google Scholar
• Koch A, Joosten SC, Feng Z, et al. Analysis of DNA methylation in cancer: location revisited. Nat Rev Clin Oncol. 2018 Jul;15(7):459–466. PubMed PMID: 29666440; eng.
   PubMed Web of Science ®Google Scholar
• Ma F, Li G, Yu Y, et al. MiR-33b-3p promotes chondrocyte proliferation and inhibits chondrocyte apoptosis and cartilage ECM degradation by targeting DNMT3A in osteoarthritis. Biochem Biophys Res Commun. 2019 Nov 5;519(2):430–437. PubMed PMID: 31522815; eng.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu K, Tang C, et al. Long non-coding RNA XIST contributes to osteoarthritis progression via miR-149-5p/DNMT3A axis. Biomed Pharmacother. 2020 Aug;128:110349. PubMed PMID: 32521454; eng.
   PubMed Web of Science ®Google Scholar